We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, James Battiste is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2018 — 2021 |
Battiste, James |
P20Activity Code Description: To support planning for new programs, expansion or modification of existing resources, and feasibility studies to explore various approaches to the development of interdisciplinary programs that offer potential solutions to problems of special significance to the mission of the NIH. These exploratory studies may lead to specialized or comprehensive centers. |
Analysis of Migration Associated Treatment Resistance in Glioblastoma to Identify Novel Therapeutics @ University of Oklahoma Hlth Sciences Ctr
The migration and invasion of malignant Glioblastoma (GBM) cells into normal brain parenchyma is fundamentally different than other biological conditions because the biophysical properties of the brain microenvironment are differ from other tissues. These microenvironmental processes contribute to chemotherapy resistance. New microfluidic ex vivo devices, that simulate the microenvironment of tumor cells in the brain, will be used to evaluate the roll of active cell migration through confined spaces in developing treatment resistance by (1) isolating and enriching clonal populations resistant to temozolomide and able to migrate, and (2) testing the roll of candidate genes for chemotherapy resistance. Cell cultures and patient derived stem cell lines will be enriched for migrating and treatment resistance cells to establish clonal populations from heterogeneous cultures. These enrichment techniques will serve as future substrates for treatment resistance models. By preliminary and reported data, ABCG2 is involved in GBM cell migration and treatment resistance. Using the microfluidic channels, the expression pattern and role of ABCG2 will be evaluated for ABCG2 necessity (expression knockdown and inhibitor) and sufficiency (overexpression). We will analyze the expression pattern of ABCG2 to migration, pre-migration, during active migration and post- migration. These results will add to our knowledge of GBM cell migration and establish a platform to test new agents to sensitize migrating cells to conventional treatments.
|
0.943 |